Jacques Van Rooyen
Research Subjects
Research Interests
Jacques Van Rooyen has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
A. K. Jonassen
Institute of Biomedicine University of Bergen Bergen Norway
1 shared publicationA. Wergeland
Institute of Biomedicine University of Bergen Bergen Norway
1 shared publication- Anna Haw
Maliasili, Essex Junction, VT, United States; Brain Function Research Group, School of Physiology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
1 shared publication - Anna-Mart Engelbrecht
Department of Physiological Sciences, Faculty of Science, Stellenbosch University, Stellenbosch, South Africa
1 shared publication B. J. N. Sishi
Department of Physiological Sciences Stellenbosch University Stellenbosch South Africa
1 shared publication- Barbara Szeiffova Bacova
Centre of Experimental Medicine, Institute for Heart Research, Slovak Academy of Sciences, Bratislava, Slovakia
1 shared publication
Latest Publications
- 10 February 2023
- Published by National Inquiry Services Center (NISC) in African Journal of Range & Forage Science
- Vol. 40 (1) , 32-46
Kraals or bomas increase soil carbon and fertility across several biomes
Knowledge about how pastoralism and kraaling may contribute to desired global objectives, such as soil fertility, is in danger of being lost. We tested whether short duration kraaling increases soi...
- 10 February 2023
- Published by National Inquiry Services Center (NISC) in African Journal of Range & Forage Science
- Vol. 40 (1) , 32-46
Kraals or bomas increase soil carbon and fertility across several biomes
Knowledge about how pastoralism and kraaling may contribute to desired global objectives, such as soil fertility, is in danger of being lost. We tested whether short duration kraaling increases soi...
- 1 September 2016
- Published by Wolters Kluwer Health in Journal Of Hypertension
- Vol. 34 (Supplement) , e270-e271
MPS 11-07 CARDIOPROTECTIVE ACTIONS OF RED PALM OIL IN SPONTANEOUSLY HYPERTENSIVE RATS
Red palm oil (RPO) has been shown to protect the heart in various cardiovascular disease models. The purpose of this study was to investigate whether intake of antioxidant-rich RPO may affect endothelial dysfunction and oxidative stress known as important mediators in the pathophysiology of hypertension as well as proarrhythmic abnormalities of myocardial connexin43 (Cx43) and PKC epsilon (PKCε) signaling, in a model of essential hypertension. 3 months old male spontaneously hypertensive (SHR) and normotensive Wistar-Kyoto rats (WKY) were fed standard rat chow plus or minus RPO (200ul/day) for 5 weeks. Left ventricular tissue was used to determine protein expression of Cx43, PKCε and antioxidant enzyme- superoxide dismutase 2 (SOD2). Total NOS activity was measured in the aorta and left ventricular tissue. Langendorff-perfused rat heart was used to examine electrically inducible ventricular fibrillation (VF) and post-ischemic reperfusion-induced malignant arrhythmias. RPO supplementation significantly reduced blood pressure in SHR and blood glucose in both SHR and WKY. Protein expression of Cx43, PKCε and SOD2 was significantly increased in a group of SHRrpo. These results were associated with decrease of postischemic reperfusion-related ventricular tachycardia and VF inducibility. NOS activity was increased in the aorta but reduced in the hearts of both WKYrpo and SHRrpo compared to their respective controls. Results indicate that SHR benefit from RPO intake, particularly due its endothelial function maintenance by improved NO production in the aorta, by apparent anti-arrhythmic and postischemia-related cardioprotective effects and via reduction of oxidative stress. It appears that RPO supplementation in combination with antihypertensive drugs may reduce the risk from heart failure and malignant arrhythmias in patients suffering from hypertension. Supported by VEGA grants 2/0167/15, 2/0076/16, SKS grant.
- 1 September 2016
- Published by Wolters Kluwer Health in Journal Of Hypertension
- Vol. 34 (Supplement) , e270-e271
MPS 11-07 CARDIOPROTECTIVE ACTIONS OF RED PALM OIL IN SPONTANEOUSLY HYPERTENSIVE RATS
Red palm oil (RPO) has been shown to protect the heart in various cardiovascular disease models. The purpose of this study was to investigate whether intake of antioxidant-rich RPO may affect endothelial dysfunction and oxidative stress known as important mediators in the pathophysiology of hypertension as well as proarrhythmic abnormalities of myocardial connexin43 (Cx43) and PKC epsilon (PKCε) signaling, in a model of essential hypertension. 3 months old male spontaneously hypertensive (SHR) and normotensive Wistar-Kyoto rats (WKY) were fed standard rat chow plus or minus RPO (200ul/day) for 5 weeks. Left ventricular tissue was used to determine protein expression of Cx43, PKCε and antioxidant enzyme- superoxide dismutase 2 (SOD2). Total NOS activity was measured in the aorta and left ventricular tissue. Langendorff-perfused rat heart was used to examine electrically inducible ventricular fibrillation (VF) and post-ischemic reperfusion-induced malignant arrhythmias. RPO supplementation significantly reduced blood pressure in SHR and blood glucose in both SHR and WKY. Protein expression of Cx43, PKCε and SOD2 was significantly increased in a group of SHRrpo. These results were associated with decrease of postischemic reperfusion-related ventricular tachycardia and VF inducibility. NOS activity was increased in the aorta but reduced in the hearts of both WKYrpo and SHRrpo compared to their respective controls. Results indicate that SHR benefit from RPO intake, particularly due its endothelial function maintenance by improved NO production in the aorta, by apparent anti-arrhythmic and postischemia-related cardioprotective effects and via reduction of oxidative stress. It appears that RPO supplementation in combination with antihypertensive drugs may reduce the risk from heart failure and malignant arrhythmias in patients suffering from hypertension. Supported by VEGA grants 2/0167/15, 2/0076/16, SKS grant.
- 16 May 2011
- Published by Wiley in Cell Biochemistry and Function
- Vol. 29 (5) , 356-364
Dietary red palm oil protects the heart against the cytotoxic effects of anthracycline
Strong anti‐neoplastic anthracyclines like daunorubicin (DNR) and doxorubicin (DOX) have high efficacy against systemic neoplasm and solid tumours. However, clinically, they cause chronic cardiomyopathy and congestive heart failure. Red palm oil (RPO) supplementation can protect the heart against ischemic injury. We therefore hypothesize that supplementation with RPO during chemotherapy may protect the heart.Control rats received a standard diet, and the experimental group received RPO in addition for 4 weeks. Each group was subsequently injected with either saline or DNR over a 12‐day period towards the end of 4 weeks. Hearts were excised and perfused on a working heart system. Functional parameters were measured. Tissue samples were collected for analysis of mRNA and protein levels. DNR + RPO increased aortic output by 25% (p < 0·05) compared with DNR only. Furthermore, DNR treatment significantly reduced tissue mRNA levels of superoxide dismutase 1 (SOD1) and nitric oxide synthase 1 (NOS1) compared with untreated controls. Protein expression of SOD1 followed the same pattern as mRNA levels. NOS1 protein levels were significantly increased in DNR treated rats when compared with untreated controls. In addition, DNR increased phosphorylation of p38 and Jun N‐terminal kinase compared with untreated controls, whereas DNR + RPO completely counteracted this activation. DNR + RPO significantly up regulated the protein extracellular signal‐regulated kinase 1 level compared with DNR only.In this model of DNR treatment, RPO is associated with stabilization of important antioxidant enzymes such NOS and SOD, and inhibition of the ‘stress’ induced mitogen‐activated protein kinase pathways. Dietary RPO also maintained function, similar to control, in DNR treated hearts. Copyright © 2011 John Wiley & Sons, Ltd.
- 16 May 2011
- Published by Wiley in Cell Biochemistry and Function
- Vol. 29 (5) , 356-364
Dietary red palm oil protects the heart against the cytotoxic effects of anthracycline
Strong anti‐neoplastic anthracyclines like daunorubicin (DNR) and doxorubicin (DOX) have high efficacy against systemic neoplasm and solid tumours. However, clinically, they cause chronic cardiomyopathy and congestive heart failure. Red palm oil (RPO) supplementation can protect the heart against ischemic injury. We therefore hypothesize that supplementation with RPO during chemotherapy may protect the heart.Control rats received a standard diet, and the experimental group received RPO in addition for 4 weeks. Each group was subsequently injected with either saline or DNR over a 12‐day period towards the end of 4 weeks. Hearts were excised and perfused on a working heart system. Functional parameters were measured. Tissue samples were collected for analysis of mRNA and protein levels. DNR + RPO increased aortic output by 25% (p < 0·05) compared with DNR only. Furthermore, DNR treatment significantly reduced tissue mRNA levels of superoxide dismutase 1 (SOD1) and nitric oxide synthase 1 (NOS1) compared with untreated controls. Protein expression of SOD1 followed the same pattern as mRNA levels. NOS1 protein levels were significantly increased in DNR treated rats when compared with untreated controls. In addition, DNR increased phosphorylation of p38 and Jun N‐terminal kinase compared with untreated controls, whereas DNR + RPO completely counteracted this activation. DNR + RPO significantly up regulated the protein extracellular signal‐regulated kinase 1 level compared with DNR only.In this model of DNR treatment, RPO is associated with stabilization of important antioxidant enzymes such NOS and SOD, and inhibition of the ‘stress’ induced mitogen‐activated protein kinase pathways. Dietary RPO also maintained function, similar to control, in DNR treated hearts. Copyright © 2011 John Wiley & Sons, Ltd.